Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 08. Mai 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8904  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178070  
   
Abdominal disseminated lesions following surgery for a testicular mucinous cystic neoplasm initially diagnosed as mucinous cystadenoma: a case report and literature review.
Front Oncol
Yang J, Li W, Wang J, Li J.
PMID: 42100427 [PubMed]


Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential.
Front Oncol
Pan M, Tao T, Kong D, Gong H.
PMID: 42100416 [PubMed]


Mechanistic insights and molecular therapy for neuroendocrine prostate cancer.
Front Oncol
Niu Y, Zhang S, Zhang S, Tao J, Zhu Y.
PMID: 42100391 [PubMed]


Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases.
Front Mol Biosci
Rodzo.
PMID: 42100367 [PubMed]


Solitary fibrous tumor: A contender in the differential diagnosis of a renal mass.
Indian J Urol
Kareem Z.
PMID: 42099838 [PubMed]


Machine learning-based integration of systemic immune-inflammation and nutritional signatures for predicting disease-free survival in upper tract urothelial carcinoma: a multicenter study.
Front Immunol
Peng X, Xiao B, Yuan Z, Xv Y, Xiao M, Shi W.
PMID: 42099622 [PubMed - indexed for MEDLINE]


Gut microbiota and its metabolites: Key factors of drug resistance in the treatment of advanced prostate cancer (Review).
Mol Med Rep
Song J, Cui H, Yang P, Xu Y, Liu Y, Zhang G, Liu Y, Tian A, Che J, Sun H, Zhang Z.
PMID: 42099232 [PubMed - indexed for MEDLINE]


FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate.
Histopathology
Zhao J, Yao J, Hosseini H, Baraban E, Lin R, Guo CC, Huo L, Lu W, Khan K, Wang S, Soto LMS, Ding Q.
PMID: 42098986 [PubMed - as supplied by publisher]


Prostate cancer therapeutic strategies decided based on in-bore MRI-targeted prostate biopsies alone, or in combination with TRUS-guided biopsies.
World J Urol
Schull A, Gachet J, Tavolaro S, Santy A, Bornet G.
PMID: 42098380 [PubMed - indexed for MEDLINE]


Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.
Nat Commun
Sharma P, Krainer M, Saad F, Castellano D, Bedke J, Kwiatkowski M, Patnaik A, Procopio G, Wiechno P, Kochuparambil S, Thomas C, Arranz Arija JÁ, McCune SL, Hansen S, Daugaard G, Delgado Mingorance JI, Kukard C, Subudhi SK, Basu S, Jindal S, Siddiqui BA, Lako A, Gupta S, Fedorov V, Amin NP, Campos A, Wang Y, David JM, Pachynski RK.
PMID: 42098105 [PubMed - as supplied by publisher]


Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets and DNA Methylation-Mediated Regulation in Urological Malignancies.
Technol Cancer Res Treat
Li T, Wei Q.
PMID: 42098041 [PubMed - indexed for MEDLINE]


Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.
BMJ Open
Cooper S, Alexander S, Breitkreutz D, Casey F, Christodouleas J, Dassen MG, Dell'acqua V, Dunlop A, Herbert T, Kolias P, Mitchell A, Pos FJ, Westley R, Tree AC, Van Der Heide UA, Vesprini D.
PMID: 42097645 [PubMed - indexed for MEDLINE]


Outdoor air pollution and prostate cancer risk in the NIH-AARP diet and health study.
J Natl Cancer Inst
Post LM, Hurwitz L, Fisher JA, Kaufman JD, Koutros S, Jones RR.
PMID: 42097289 [PubMed - as supplied by publisher]


Optimizing Care for Patients With Metastatic Castration-Resistant Prostate Cancer.
Am Soc Clin Oncol Educ Book
Cren PY, Buteau J, Fatema U, Patel R, Saraiya B, Emmett L, Fizazi K.
PMID: 42096668 [PubMed - indexed for MEDLINE]


Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE).
J Clin Oncol
McKay RR, Xie W, Ajmera A, Araneta A, Jamieson C, Folefac E, Hussain A, Kyriakopoulos CE, Manning DK, Olson A, Parikh M, Parikh R, Saraiya B, Pasquina LW, Madison R, Clifford S, Childress M, Gasco A, Ivy P, Van Allen E, Kochupurakkal B, Shapiro GI.
PMID: 42096662 [PubMed - as supplied by publisher]


Autoencoder/RandomForest-TabPFN for Cross-Cancer Metabolomics: Prostate and Breast Cancer Diagnosis Using Paper Spray and Ion Mobility-Mass Spectrometry Techniques.
Gigascience
Hauns S, Pinto FG, Khyriem C, Singh A, Al-Sadi A, Yazeedi TA, Mohammad R, Cisse B, Garrett TJ, Uddin M, Soares NC, Backofen R, Alkhnbashi OS.
PMID: 42096511 [PubMed - as supplied by publisher]


[Solitary fibrous tumor of the prostate mimicking a tumor of the vesicoprostatic junction. Case report].
Rev Med Inst Mex Seguro Soc
Díaz-Fuentes H, Zapot-Martínez JC, Cabrera-Mora NA, Ramos-Arceo E, Tavares-García JS.
PMID: 42096255 [PubMed - indexed for MEDLINE]


[First cohort: Robotic radical prostatectomy at the Mexican Institute for Social Security].
Rev Med Inst Mex Seguro Soc
Fuziwara-Ruíz S, Hernández-Toriz N, Huerta-Gómez JC, Quintero-Becerra J, Martínez-Cornelio A, Zapot-Martínez JC, Delgado-Herrera A, Castro-Chávez C, Pérez-Ramírez O.
PMID: 42095811 [PubMed - indexed for MEDLINE]


Urologist and radiologist contributions to variation in prostate cancer detection at fusion biopsy.
BJU Int
Triner D, Ginsburg KB, Moser A, Labardee C, Korman H, Domina J, Cher ML, Peabody J, Semerjian A, Purysko A, George AK, Borza T, Krumm AE, Michigan Urological Surgery Improvement Collaborative (MUSIC).
PMID: 42095733 [PubMed - as supplied by publisher]


The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.
Clin Cancer Res
Pakvisal N, Wongkongkathep P, Bunrasmee W, Sodsai P, Siriluksana J, Boonnak N, Sangcharoen T, Trakarnsanga B, Sukprakun S, Wantanasiri P, Chotirosniramit K, Phanichkrivalkosil M, Nanthawong S, Chanchaem P, Mankhong S, Kumpunya S, Supabphol S, Sirijun N, Kongtragulsub K, Pearngam P, Somparn P, Payne DM, Zhao B, Praphanphoj V, Pornputtapong N, Sriswasdi S, Wichadakul D, Uttamapinan S, Angspatt P, Wongchanapat P, Teeyapun N, Luangdilok S, Sitthideatphaiboon P, Susiriwatananont T, Zungsontiporn N, Parinyanitikul N, Tanasanvimon S, Vinayanuwattikun C, Salazar A, Hirankarn N, Sriuranpong V, Pisitkun T.
PMID: 42095629 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 178070    Seite 1 von 8904  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1